Urine HPV test for cervical cancer screening in HIV
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at whether testing for HPV (the virus that can lead to cervical cancer) using a urine sample can help with cervical cancer screening. It’s for women living with HIV, who may be at higher risk and need effective, easy screening.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed HIV-1 infection.
- You are 25 years old or older.
- You can read, understand, and sign written informed consent.
- You are not pregnant and do not plan to become pregnant in the next 90 days.
- You have not had cervical cancer screening in the last 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different ways to screen for cervical cancer in women living with HIV. It aims to find the most effective and practical screening approach for this group.
This trial studies whether letting people collect their own HPV test sample (a private, at-home option) makes cervical cancer screening easier for people with HIV and/or those who are often underserved. If you’ve declined a Pap test or it’s been 6+ months since your last screening, this may offer a more convenient way to check for HPV and cervical cancer risk.
This study looks at how HPV (the virus that can cause cervical cancer) and the natural balance of bacteria in the vagina affect women who have HIV. It may help doctors understand how to better prevent cervical cancer in women with weakened immune systems.
This study looks at ways to improve cervical cancer screening and follow-up for women with HIV. If you are a woman with HIV aged 25 or older, this research may help understand how to make screening easier and more available.
This trial tests a new way to prevent cervical cancer in women with both HIV and HPV. It focuses on women in India who are already on stable HIV treatment and have a normal cervical exam.
This study tests a self-collection kit for HPV, a virus that can cause cervical cancer. It aims to make screening easier for women with HIV who haven't had a Pap test recently, and to find earlier signs of risk.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.